Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Common Share (Tables)

v3.24.1.1.u2
Net Loss per Common Share (Tables)
3 Months Ended
Mar. 31, 2024
Net Loss per Common Share  
Schedule of Diluted Weighted Average Shares Outstanding

    

Three Months Ended March 31, 

2024

    

2023

Warrants to purchase Common Stock

 

5,769,788

 

127,296

Options to purchase Common Stock

 

18,896

 

41,508

Unvested Restricted Stock

 

1,725,726

 

1,379,934

Unvested Restricted Stock Units

 

1,267

 

71

Total

 

7,515,677

 

1,548,809